WaveMan
WaveMan · Company
KIDS · Orthopediatrics Corp
> Search tickers & screens ⌘K
LIVE
← All companies

KIDS Orthopediatrics (KIDS) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0001425450
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
70
13F, latest reported quarter

What the filings say about KIDS

Insiders, 180 days
-$46.7M net sold
3 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$18.4M
1 notice

Orthopediatrics insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, ORTHOPEDIATRICS CORP insiders sold a net $46.7M of stock across 78 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
SELL
2026-09-10 SEC
302,369
$6.4M
+11.1%
Context
  • 7 earlier Form 4 trades (code P or S) here by this insider (1 buy, 6 sales), the last on Sep 2, 2026.
  • The trade is 4.9% of the 6,201,764 shares held after it.
  • 2 other insiders sold within 30 days.
  • 70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Pelizzon David R sold about $6.4M of KIDS on Sep 10, 2026; 2 other insiders sold within 30 days and 70 funds added in the latest 13F quarter.
SELL
2026-09-11 SECtraded 2026-09-10
302,369
$6.4M
+9.7%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (7 buys, 6 sales), the last on Sep 2, 2026.
  • -9.0% median (-9.3% mean) 90-day return after 3 previous buys.
  • The trade is 4.9% of the 6,201,764 shares held after it.
  • 2 other insiders sold within 30 days.
  • 70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Pritzker Jennifer N. sold about $6.4M of KIDS on Sep 10, 2026; 2 other insiders sold within 30 days and 70 funds added in the latest 13F quarter.
SELL
2026-09-11 SECtraded 2026-09-10
302,369
$6.4M
+9.7%
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Sep 2, 2026.
  • The trade is 4.9% of the 6,201,764 shares held after it.
  • 2 other insiders sold within 30 days.
  • 70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Squadron Capital LLC sold about $6.4M of KIDS on Sep 10, 2026; 2 other insiders sold within 30 days and 70 funds added in the latest 13F quarter.
SELL
2026-09-04 SECtraded 2026-09-02
22,500
$525.4K
+10.3%
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (1 buy, 5 sales), the last on Sep 1, 2026.
  • The trade is 0.3% of the 6,504,133 shares held after it.
  • 2 other insiders sold within 30 days.
  • 70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Pelizzon David R sold about $525.4K of KIDS on Sep 2, 2026; 2 other insiders sold within 30 days and 70 funds added in the latest 13F quarter.
SELL
2026-09-04 SECtraded 2026-09-02
22,500
$525.4K
+10.3%
Context
  • 12 earlier Form 4 trades (code P or S) here by this insider (7 buys, 5 sales), the last on Sep 1, 2026.
  • -9.0% median (-9.3% mean) 90-day return after 3 previous buys.
  • The trade is 0.3% of the 6,504,133 shares held after it.
  • 2 other insiders sold within 30 days.
  • 70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Pritzker Jennifer N. sold about $525.4K of KIDS on Sep 2, 2026; 2 other insiders sold within 30 days and 70 funds added in the latest 13F quarter.
78 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 73 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$46.7M over 180 days
-$46.7M over 90 days · -$46.7M of it by a 10%+ holder
below 96% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
70 funds bought in last quarter
more than 54% of Medical Devices
Revenue
+15.4% year over year
more than 61% of Medical Devices
Margin
-16.8% net margin
below 51% of Medical Devices
Buybacks
no share repurchases reported
Short interest
5.1% of the float short (float per yahoo 2026-10-26) · 5.5 days to cover · settled 2026-09-30
more than 51% of Medical Devices
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch KIDS

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+37.0%12M
-18%+4%+26%+48%2025-102025-122026-022026-042026-062026-082026-10 2026-08-28 · Pelizzon David R sold $7.5M2026-08-28 · Pritzker Jennifer N. sold $7.5M2026-08-28 · Squadron Capital LLC sold $7.5M2026-09-10 · Pelizzon David R sold $6.4M2026-09-10 · Pritzker Jennifer N. sold $6.4M2026-09-10 · Squadron Capital LLC sold $6.4M2026-09-02 · Pelizzon David R sold $525.4K2026-09-02 · Pritzker Jennifer N. sold $525.4K2026-09-02 · Squadron Capital LLC sold $525.4K2026-08-26 · Pelizzon David R sold $437.0K2026-08-26 · Pritzker Jennifer N. sold $437.0K2026-08-26 · Squadron Capital LLC sold $437.0K2026-08-25 · Pelizzon David R sold $403.3K2026-08-25 · Pritzker Jennifer N. sold $403.3K2026-08-25 · Squadron Capital LLC sold $403.3K2026-03-16 · Bailey David R sold $337.0K2026-09-01 · Pelizzon David R sold $234.0K2026-09-01 · Pritzker Jennifer N. sold $234.0K2026-09-01 · Squadron Capital LLC sold $234.0K2026-03-16 · Hite Fred sold $224.1K2026-03-16 · Gerritzen Daniel J sold $148.6K2026-03-16 · Hauser Joseph W sold $148.3K2026-03-16 · Odle Gregory A sold $145.5K2026-08-24 · Pelizzon David R sold $103.0K2026-08-24 · Pritzker Jennifer N. sold $103.0K2026-08-24 · Squadron Capital LLC sold $103.0K2026-08-24 · Squadron Capital, LLC filed to sell $18.4M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns KIDS: institutional holders (13F)

13F holdings, latest reported quarter
1,678,983 sh
$32.1M
1,272,714 sh
$24.3M
1,100,370 sh
$21.1M

Congress trades in KIDS

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

KIDS planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Squadron Capital, LLC
Filed 2026-08-24
$18.4M

KIDS mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Wasatch Micro Cap Fund
$9.8M position · as of 2026-06-30
1.4%
Harbor Active Small Cap Growth ETF
$368.7K position · as of 2026-07-31
1.4%
Brown Advisory Small-Cap Growth Fund
$6.7M position · as of 2026-06-30
1.1%
Buffalo Early Stage Growth Fund
$475.8K position · as of 2026-06-30
0.6%
Embark Small Cap Equity Fund
$4.0M position · as of 2026-07-31
0.6%
Brown Capital Management Small Company Fund
$1.8M position · as of 2026-06-30
0.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $46.7M sold by insiders over 180 days, 70 funds added last quarter, $18.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

KIDS financials

Revenue growth
+15.4%
XBRL, annual
Net margin
-16.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$252.7M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-15.7%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$1.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.30x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
0.07x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
-11.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-7.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-6.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$724.7M
market value at close 2026-10-23 on 2026-08-04 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
-0.3%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$236.3M$204.7M$148.7M$122.3M
Gross profit$172.7M$148.6M$111.3M$90.7M
Operating income-$39.2M-$35.0M-$26.8M-$25.4M
Net income-$39.6M-$37.8M-$21.0M$1.3M
EPS (diluted)-1.69-1.64-0.920.06
Operating cash flow-$4.9M-$27.0M-$27.0M-$21.8M
Cash$19.6M$43.8M$31.1M$9.0M
Long-term debt$99.8M$73.0M$9.9M$763.0K
SEC XBRL, fiscal years, as known on 2026-10-27

KIDS Stock Sonar score 6/7 axes

Find similar shapesCompare

KIDS ranks highest on risk and compliance (79th percentile) and growth (61st), and lowest on insider conviction (1st), among Medical Devices peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
58
Inputs
  • Return on equity-11.4% · 55 pct, sector of 183
  • Return on assets-7.8% · 58 pct, sector of 214
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-6.5% · 60 pct, sector of 188
Financial health
54
Inputs
  • Debt to equity0.30x · 50 pct, sector of 159
  • Cash flow to debt0.07x · 57 pct, sector of 150
Growth
61
Inputs
  • Revenue growth, YoY+15.4% · 61 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
1
Inputs
  • Net Form 4 buying (codes P and S), 180d-$46.7M · 3 pct, sector of 140
  • Insider buyers, 180d0 · 0 pct, sector of 142
Institutional and government
54
Inputs
  • Funds adding, latest quarter70 · 54 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
79
Inputs
  • Short interest, % of float+5.1% · 48 pct, sector of 240
  • Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 116
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+3.6% · 89 pct, sector of 198
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

KIDS filings, in plain words

Are Orthopediatrics insiders buying or selling KIDS?

In the 180 days to 2026-10-27, Orthopediatrics insiders were net sellers, a net $46.7M across purchases and sales reported on Form 4, by 3 sellers.

Are there planned insider sales of KIDS?

Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $18.4M of stock; the latest, by Squadron Capital, LLC, was filed 2026-08-24.

Read the full summary

In the 180 days to 2026-10-27, Orthopediatrics insiders were net sellers of KIDS, a net $46.7M across purchases and sales reported on Form 4 by 3 sellers. Most of that figure, $46.7M, came from a holder of 10% or more rather than an officer or director. None of the 21 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $18.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing